Abstract:An effective anti-tumor immune response requires the coordinated action of the innate and adaptive phases of the immune system. Critical processes include the activation of dendritic cells to present antigens, produce cytokines including type I interferons, and express multiple costimulatory ligands; induction of a productive T cell response within lymph nodes; migration of activated T cells to the tumor microenvironment in response to chemokines and homing receptor expression; and having effector T cells gain access to antigen-expressing tumor cells and maintain sufficient functionality to destroy them. However, tumors can become adept at escaping the immune response, developing multiple mechanisms to disrupt key processes. In general, tumors can be assigned into two different, major groups depending on whether the tumor there is an ‘inflamed’ or ‘non-inflamed’ tumor microenvironment. Improvements in our understanding of the interactions between the immune system and cancer have resulted in the development of various strategies to improve the immune-mediated control of tumors in both sub-groups. Categories of major immunotherapeutic intervention include methods to increase the frequency of tumor antigen-specific effector T cells in the circulation, strategies to block or uncouple a range of immune suppressive mechanisms within the tumor microenvironment, and tactics to induce de novo immune inflammation within the tumor microenvironment. The latter may be particularly important for eliciting immune recognition of non-inflamed tumor phenotypes. The premise put forth in this review is that synergistic therapeutic effects in vivo may be derived from combination therapies taken from distinct “bins” based on these mechanisms of action. Early data in both preclinical and some clinical studies provide support for this model. We also suggest that optimal application of these combinations may be aided by appropriate patient selection based on predictive biomarkers.

Toward innovative combinational immunotherapy: A systems biology perspective

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment

Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System

Prospects for combining targeted and conventional cancer therapy with immunotherapy

Rational combinations of immunotherapeutics that target discrete pathways

Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights

Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2

Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy

Emerging strategies in cancer therapy combining chemotherapy with immunotherapy.

Advances of combined immunotherapy in tumor

Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment

Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies.

Next-generation combination approaches for immune checkpoint therapy

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies

Facts and hopes in using omics to advance combined immunotherapy strategies

Combined Targeted Therapy and Immunotherapy for Cancer Treatment